Intracerebral administration of interleukin-12 (IL-12) and IL-18 modifies the course of mouse scrapie

BMC Vet Res. 2006 Dec 27:2:37. doi: 10.1186/1746-6148-2-37.

Abstract

Background: Prion diseases are characterised by a neurodegenerative pattern in which the function of immune system remains still elusive. In the present study, we evaluate if an exogenous treatment with Interleukin-12 (IL-12) and IL-18, able to activate microglia, is able to affect scrapie pathogenesis.

Results: Cytokines injected intracranially, induced a strong inflammatory response characterised by TNF-alpha production and microglia activation. Two groups of mice were injected intracerebrally with high dose of ME7 strain of scrapie containing IL-12 and IL-18 or sterile saline. Cytokines-treated mice showed a more pronounced accumulation of PrPSc in brain tissues at 90 days post-inoculation and a shorter mean survival times than untreated mice.

Conclusion: We can conclude that intracerebral administration of IL-12 and IL-18 can modulate scrapie pathogenesis possibly through a microglia-mediated pattern.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drug Therapy, Combination
  • Female
  • Injections, Intraventricular
  • Interferon-gamma / metabolism
  • Interleukin-12 / administration & dosage*
  • Interleukin-12 / therapeutic use*
  • Interleukin-18 / administration & dosage*
  • Interleukin-18 / therapeutic use*
  • Mice
  • Mice, Inbred C57BL
  • Scrapie / drug therapy*
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-18
  • Tumor Necrosis Factor-alpha
  • Interleukin-12
  • Interferon-gamma